144 (Pantoprazole sodium delayed release 20 mg)
Pill imprint 144 has been identified as Pantoprazole sodium delayed release 20 mg.
Pantoprazole is used in the treatment of barrett's esophagus; gerd; dumping syndrome; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 144
- Strength:
- 20 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- 47335-0144
- Inactive Ingredients:
- mannitol
sodium carbonate
lactose anhydrous
crospovidone
povidone
calcium stearate
hypromelloses
polyethylene glycol
magnesium silicate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
triethyl citrate
titanium dioxide
ferric oxide yellow
shellac
isopropyl alcohol
butyl alcohol
propylene glycol
ammonia
ferrosoferric oxide
More about pantoprazole
Consumer resources
- Pantoprazole,
- Pantoprazole
- Pantoprazole delayed-release tablets
- Pantoprazole suspension
- Pantoprazole (Advanced Reading)
- Pantoprazole Intravenous (Advanced Reading)
- Other brands: Protonix, Protonix IV
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
